% latex table generated in R 3.5.1 by xtable 1.8-3 package
% Thu Dec 20 11:10:49 2018
\begin{table}[ht]
\centering
\begin{tabular}{rlllllllllllllllllllll}
  \hline
 &      Rank &                                                                                                                                                                                                                                                                                                                                                              Title &   Citations &   Citations.Density. &    Density &                                                        First.Author &                                                    Last.Author &      Year &      Age & Level.of.Evidence &           Article.Type &               Classification &                   Field &     Author.Country &                              Departments.and.Sections &                                     Instituition &      Continent &         Journal &                                   Journal.Full.Name & Journal.Publisher.Country & Quartile.in.Category \\ 
  \hline
X & Min.   :  1.00   & Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2545-59.                                                                                                                                                                                             : 1   & Min.   : 4021   & 10843(434) : 1   & Min.   :  73.0   & Flegal KM                                                    : 2   & Memish ZA                                                : 3   & Min.   :1963   & Min.   : 4.00   & I  : 5   & Original Article:87   & RCT                  :39   & Cardiology           :28   & USA        :63   & Department of Medicine                   :14   & Harvard University                        :10   & Europe    :29   & BMJ         : 4   & British Medical Journal                    : 4   & UK : 4   & Q1:100   \\ 
  X.1 & 1st Qu.: 25.75   & Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1301-8.                                                                                                                        : 1   & 1st Qu.: 4313   & 10919(642) : 1   & 1st Qu.: 217.8   & Murray CJ                                                    : 2   & Altman DG                                                : 2   & 1st Qu.:1996   & 1st Qu.:13.00   & II :50   & Review Article  :13   & Cross-sectional study:16   & Oncology             :19   & UK         :16   & Department of Pathology                  : 5   & McMaster University                       : 7   & Non-Europe:71   & JAMA        :17   & Journal of The American Medical Association:17   & USA:96   &  \\ 
  X.2 & Median : 50.50   & Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome--a new worldwide definition. Lancet. 2005 Sep 24-30;366(9491):1059-62.                                                                                                                                                                                        : 1   & Median : 5030   & 12581(839) : 1   & Median : 314.5   & Ogden CL                                                     : 2   & Flegal KM                                                : 2   & Median :2001   & Median :17.00   & III: 7   &  & Systematic Review    :14   & Public Health        :13   & Canada     : 8   & Division of Cardiology                   : 5   & Centers for Disease Control and Prevention: 6   &  & Lancet      :21   & Lancet                                     :21   &  &  \\ 
  X.3 & Mean   : 50.50   & Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?. Lancet. 2001 Feb 17;357(9255):539-45.                                                                                                                                                                                                                                                       : 1   & Mean   : 6179   & 16559(872) : 1   & Mean   : 397.6   & Ridker PM                                                    : 2   & Folkman J                                                : 2   & Mean   :1999   & Mean   :19.11   & IV :10   &  & Clinical Consensus   :10   & Endocrinology        :10   & Sweden     : 2   & Clinical Trial Service Unit              : 4   & University of Oxford                      : 5   &  & N Engl J Med:57   & New England Journal of Medicine            :57   &  &  \\ 
  X.4 & 3rd Qu.: 75.25   & Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001 Mar 8;344(10):699-709.: 1   & 3rd Qu.: 6180   & 19428(925) : 1   & 3rd Qu.: 496.2   & Ross R                                                       : 2   & National Cancer Institute of Canada Clinical Trials Group: 2   & 3rd Qu.:2005   & 3rd Qu.:22.25   & V  :28   &  & Case Series          : 8   & Quality of Reporting : 6   & Switzerland: 2   & Department of Surgery                    : 3   & University of Washington                  : 5   &  & PLoS Med    : 1   & Plos Medicine                              : 1   &  &  \\ 
  X.5 & Max.   :100.00   & Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986 Feb 8;1(8476):307-10.                                                                                                                                                                                                                : 1   & Max.   :31853   & 20319(2258): 1   & Max.   :2258.0   & Action to Control Cardiovascular Risk in Diabetes Study Group: 1   & Ross R                                                   : 2   & Max.   :2014   & Max.   :55.00   &  &  & Experimental Study   : 8   & Biochemistry         : 3   & Beligium   : 1   & Institute for Health Metrics \& Evaluation: 3   & John Jopkins University                   : 3   &  &  &  &  &  \\ 
  X.6 &  & (Other)                                                                                                                                                                                                                                                                                                                                                         :94   &  & (Other)    :94   &  & (Other)                                                      :89   & (Other)                                                  :87   &  &  &  &  & (Other)              : 5   & (Other)              :21   & (Other)    : 8   & (Other)                                  :66   & (Other)                                   :64   &  &  &  &  &  \\ 
   \hline
\end{tabular}
\end{table}
